Assessing health status over time: Impact of recall period and anchor question on the minimal clinically important difference of copd health status tools

Health and Quality of Life Outcomes

Volumn 16, Issue 1, 2018, Pages

  Alma, H J ^a   de Jong, C ^a   Jelusic, D ^b   Wittmann, M ^b   Schuler, M ^c   Kollen, B J ^a   Sanderman, R ^a,d   Schultz, K ^b   Kocks, J W H ^a   Van der Molen, T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Klinik Bad Reichenhall   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease (COPD); Clinical COPD questionnaire (CCQ); Clinically relevant change; COPD assessment test (CAT); Global rating of change scale; Health status; Minimal clinically important difference; Pulmonary rehabilitation; Recall period; St. George's respiratory questionnaire (SGRQ)

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COPD QUESTIONNAIRE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; COPD ASSESSMENT TEST; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOBAL RATING OF CHANGE SCALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PULMONARY REHABILITATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPIRATORY TRACT DISEASE ASSESSMENT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; AGED; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PATHOPHYSIOLOGY; QUALITY OF LIFE; TIME FACTOR;

AGED; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 85052948176     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-018-0950-7     Document Type: Article

References (57)

1. Reardon JZ, Lareau SC, Zu Wallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006;119(10 Suppl 1):32-7.
2. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880-7.
3. Jones PWHS. What does it mean for payers and patients? Proc Am Thorac Soc. 2006;3:222-6.
4. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-9.
5. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials. 1989;10:407-15.
6. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7:541-6.
7. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61:102-9.
8. Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002;14:109-14.
9. Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2009;17:163-70.
10. Grøvle L, Haugen AJ, Hasvik E, Natvig B, Brox JI, Grotle M. Patients' ratings of global perceived change during 2 years were strongly influenced by the current health status. J Clin Epidemiol. 2014;67:508-15.
11. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56:395-401.
12. Jones PW, Price D, Van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:289-96.
13. Curtis JR, Patrick DL. The assessment of health status among patients with COPD. Eur Respir J Suppl. 2003;41:36s-45s.
14. Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, Van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257-68.
15. Westwood, M., Bourbeau, J., Jones, P.W., Cerulli, A., Capkun-Niggli, G., Worthy G. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res 2011, 12: 40-9921-12-40.
16. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648-54.
17. Van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EFD. Validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13.
18. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med. 1991;85:25-31.
19. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD (2017 Report). 2017; Available at http://www.goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. Accessed 11th of July 2017.
20. Kocks JWH, Blom CMG, Kasteleyn MJ, Oosterom W, Kollen BJ, Van der Molen T, Chavannes NH. Feasibility and applicability of the paper and electronic COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in primary care: a clinimetric study. Npj Primary Care Respiratory Medicine. 2017;27(1):20.
21. Kocks JW, Tuinenga MG, Uil SM, van den Berg JW, Ståhl E, der Molen V. T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:62.
22. Kon SS, Dilaver D, Mittal M, Nolan CM, Clark AL, Canavan JL, Jones SE, Polkey MI, Man WD. The clinical COPD questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax. 2013;69:793-8.
23. Canavan JL, Dilaver D, Clark AL, Jones SE, Nolan CM, Kon SS, Man WD. Clinical COPD questionnaire in patients with chronic respiratory disease. Respirology. 2014;19:1006-12.
24. Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, Siafakas N, Tzanakis N. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med. 2012;12:20.
25. Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Flokstra-de Blok B, Kocks J, Schultz K, Van der Molen T. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. Npj PCRM. 2016;26:16041.
26. Smid DE, Franssen FM, Houben-Wilke S, Vanfleteren LE, Janssen DJ, Wouters EF, Spruit MA. Responsiveness and MCID estimates for CAT, CCQ and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysis. J Am Med Dir Assoc. 2017;18(1):53-8.
27. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2:195-203.
28. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, Falzon C, Garrod R, Lee C, Polkey MI, Jones PW, Man WD, Hopkinson NS. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. 2011;66:425-9.
29. Jones PWS. George's respiratory questionnaire: MCID. COPD. 2005;2:75-9.
30. Welling JB, Hartman JE, Ten Hacken NH, Klooster K, Slebos DJ. The minimal important difference for the St George's respiratory questionnaire in patients with severe COPD. Eur Respir J. 46:1598.
31. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med. 1997;155:1283-9.
32. Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, Lehbert N, Wingart S, Stojanovic D, Göhl O, Alma HJ, de Jong C, van der Molen T, Faller H, Schuler M. Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial. Eur Respir J 2018 Jan 25;51(1). pii: 1702000.
33. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014 Oct;44(4):873-84.
34. Zhou Z, Zhou A, Zhao Y, Chen P. Evaluating the clinical COPD questionnaire: a systematic review. Respirology. 2017 Feb;22(2):251-62.
35. Ware J.E. et al. SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute, New England Medical Center Boston, Massachusetts.
36. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34-42.
37. Afshartous D, Preston RA. Confidence intervals for dependent data: equating non-overlap with statistical significance. Computational Statistics and Data Analysis. 2010;54:2296-305.
38. Guyatt GH, Norman GR, Juniper EF, Griffith LE. A critical look at transition ratings. J Clin Epidemiol. 2002;55:900-8.
39. Stull DE, Kline Leidy N, Parasuraman B, Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin. 2009;25(4):929-42.
40. Kjellson G, Clarke P, Gerdtham UG. Forgetting to remember or remembering to forget: a study of the recall period length in health care survey questions. J Health Economics. 2014;35:34-46.
41. Schmitt JS, Abbott JH. Global ratings of change do not accurately reflect functional change over time in clinical practice. J Orthop Sports Phys Ther. 2015;45(2)
42. Schmitt JS, Abbott JH. Patient global ratings of change did not adequately reflect change over time: a clinical cohort study. Phys Ther. 2014;94:534.
43. Schmitt J, Di Fabio RP. The validity of prospective and retrospective global change criterion measures. Arch Phys Med Rehabil. 2005;86:2270-6.
44. Kamper SJ, Ostelo RW, Knol DL, Maher CG, de Vet HC, Hancock MJ. Global perceived effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. J Clin Epidemiol. 2010;63(7):760-6.
45. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol. 1997;50:869-79.
46. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain trials: IMMPACT recommendations. J Pain. 2008;9:105-21.
47. Herrmann D. Reporting current, past, and changed health status. What we know about distortion. Med Care. 1995;33(4 Suppl):AS89-94.
48. Meek PM, Lareau SC, Anderson D. Memory for symptoms in COPD patients: how accurate are their reports? Eur Respir J. 2001;18:474-81.
49. Seidl H, Meisinger C, Kirchberger I, Burkhardt K, Kuch B, Holle R. Validity of self-reported hospital admissions in clinical trials depends on recall period length and individual characteristics. J Eval Clin Pract. 2016;22:446-54.
50. Shi Q, Trask PC, Wang XS, Mendoza TR, Apraku WA, Malekifar M, Cleeland CS. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manag. 2010;40:191-9.
51. Bennett AV, Amtmann D, Diehr P, Patrick DL. Comparison of 7-day recall and daily diary reports of COPD symptoms and impacts. Value Health. 2012;15:466-74.
52. Norquist JM, Girman C, Fehnel S, DeMuro-Mercon C, Santanello N. Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration. Qual Life Res. 2012;21:1013-20.
53. Jones, P.W., Beeh, K.M., Chapman, K.R., Decramer, M., Mahler, D.A., Wedzicha, J.A. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med 2014, 1; 189(3):250-255.
54. Schwartz CE, Sprangers MAG. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531-48.
55. Ousmen A, Conroy T, Guillemin F, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Hamidou Z, Bonnetain F, Anota A. Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time. Health Qual Life Outcomes. 2016;14:16.
56. Lacasse, Y., Goldstein, R., Lasserson, T.J., Martin, S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006, 18;(4): CD003793.
57. Phillips A, Fletcher C, Atkinson G, Channon E, Douiri A, Jaki T, Maca J, Morgan D, Roger JH, Terrill P. Multiplicity: discussion points from the statisticians in the pharmaceutical industry multiplicity expert group. Pharmaceut Statist. 2013;12:255-9.